Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Directorate Changes

22 Jul 2024 09:43

RNS Number : 2809X
Cropper(James) PLC
22 July 2024
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT CONSTITUTES INSIDE INFORMATION AS STIPULATED UNDER THE UK'S MARKET ABUSE REGULATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, SUCH INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

22 July 2024

 

 

James Cropper plc

('James Cropper', the 'Company' or the 'Group')

 

Directorate Changes

 

James Cropper plc (AIM: CRPR), the Advanced Materials and Paper & Packaging group, announces that Jon Yeung will be appointed as an independent Non-Executive Director and join the Board following conclusion of the Company's AGM expected to take place in September 2024 ("AGM").

 

Jon is a chartered accountant and brings significant experience in creating shareholder value through long-term business transformation and growth. During 11 years at LGC Science Group - a global life sciences group serving a variety of end markets globally - Jon held various leadership roles, including Group Finance Director and COO/Managing Director of the £400m Standards division, during which the business saw significant growth. Prior to this Jon spent 16 years at PricewaterhouseCoopers LLP working extensively with listed businesses across audit and transaction projects including financing and M&A. Jon is currently a Non-Executive Director and Audit Committee Chair at private equity owned Fera Science. He also serves as an advisory Board member for Charterpath, a not-for-profit organisation which seeks to connect individuals with finance skills with charities.

 

Upon joining the Board, Jon will be appointed as Audit Committee Chair and will serve as a member of the Remuneration and Nomination Committees.

 

The Board also announces that Jim Sharp will stand down as a Non-Executive Director and from the Board upon conclusion of the Company's forthcoming AGM after 15 years' service.

 

Further information relating to Jon Yeung in accordance with Rule 17 and paragraph (g) of Schedule Two of the AIM Rules for Companies is set out at the end of this announcement.

 

Mark Cropper, Non-Executive Chair, commented:

 

"On behalf of the Board, I am delighted to welcome Jon to James Cropper. Jon's depth of finance, leadership and business growth experience will be hugely beneficial to the Board as we seek breakout growth in the coming years, and I look forward to working with him.

 

"I would also like to thank Jim for his unwavering support and commitment to James Cropper over the last 15 years. Jim has made a very significant contribution during his tenure, and he steps down from the Board with our sincerest gratitude."

 

 

-ENDS-

 

Enquiries:

 

James Cropper plc Mark Cropper, Non-Executive Chair

+44(0)1539 722002

 

Shore Capital - (Nominated Adviser and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0)207 408 4090

 

Burson Buchanan - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

Regulatory Disclosures:

 

Save for the information set out herein, there are no further disclosures to be made in accordance with Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Jonathan Mark Yeung (aged 51).

 

Current Directorships and Partnerships

Cricket Dorset Limited

Fera Science Limited

Hazel II Topco Limited

LGC Science and Standards (India) Private Limited

 

Past Directorships and Partnerships

9123725 Canada Inc.

Innovaspeak Limited

M.B.H. Analytical Limited

Paragon Scientific Limited

Techno-Path Manufacturing Limited

 

Notes for editors:

 

James Cropper is a market leader in Advanced Materials and Paper & Packaging, centred around four market audiences: Energy Solutions, Composite Solutions, Luxury Packaging and Creative Papers.

 

A purpose-led business, built upon six generations of the Cropper family, James Cropper has a 600+ international workforce and an operational reach in over 50 countries.

 

Established in 1845, the Group manufactures creative papers, luxury packaging and advanced materials incorporating pioneering non-wovens and electrochemical coatings.

 

James Cropper is a specialist provider of niche solutions tailored to a unique customer specification, ranging from substrates and components in hydrogen electrolysis and fuel cells to bespoke colours and textures in paper and moulded fibre packaging designed to replace single use plastics.

 

The Group operates across multiple markets from luxury retail to renewable energy. It is renowned globally for service, capability, pioneering and multi award-winning commitment to the highest standards of sustainability.

 

James Cropper's goal is to be operationally net zero by 2030 and to reduce carbon through its entire supply chain to net zero by 2050.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUPCMUPCURP
Date   Source Headline
9th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSHalf-year Report
4th Nov 20217:00 amRNSDirectorate Change
24th Sep 20211:44 pmRNSDirector/PDMR Shareholding
9th Sep 20215:35 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSGrant of Awards under Long Term Incentive Plan
5th Aug 20217:00 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 202111:00 amRNSAGM Statement and Trading Update
27th Jul 202110:27 amRNSDirector/PDMR Shareholding
23rd Jul 20219:52 amRNSDirector/PDMR Shareholding
23rd Jul 20217:00 amRNSUpdate for visitors to the AGM
21st Jul 20217:00 amRNSDirector/PDMR Shareholding
6th Jul 20217:46 amRNSDirector/PDMR Shareholding
1st Jul 20212:30 pmRNSHolding(s) in Company
22nd Jun 20218:36 amRNSDirectorate Change
22nd Jun 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSDirector Dealing
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20219:31 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSAcquisition
18th Dec 202011:05 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20202:06 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSHalf-year Report
5th Aug 20207:00 amRNSGrant of Awards under Long Term Incentive Plan
31st Jul 20207:00 amRNSDirector/PDMR Shareholding
30th Jul 20209:41 amRNSResult of AGM
29th Jul 20207:00 amRNSAGM Statement and Trading Update
27th Jul 20201:47 pmRNSDirector/PDMR Shareholding
27th Jul 20209:00 amRNSDirectorate Change
23rd Jun 20207:00 amRNSFinal Results
1st May 20207:00 amRNSYear end and COVID 19 trading update
24th Mar 20203:57 pmRNSCOVID 19 update
20th Feb 20209:45 amRNSDirector Dealing
14th Feb 202010:13 amRNSDirector Dealing
30th Jan 20208:55 amRNSDirector/PDMR Shareholding
24th Jan 20204:30 pmRNSDirector/PDMR Shareholding
21st Jan 20202:00 pmRNSHolding(s) in Company
13th Jan 202011:05 amRNSDirector/PDMR Shareholding
17th Dec 201912:24 pmRNSDirector/PDMR Shareholding
13th Dec 20197:00 amRNSDirectors' Dealings
29th Nov 201910:42 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings
9th Aug 20197:00 amRNSNotification of Transaction of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.